Multiple chemical sensitivity (MCS) is also known in research studies as Chemical Sensitivity, Chemical Intolerance, Idiopathic Environmental Illness, and Toxicant-Induced Loss of Tolerance
However, T2DM relapses occurred in a considerable number of the patients with diabetes who achieve remission through surgery [53]
Although the trial is not a conclusive verdict on semaglutides efficacy for addiction due to the small patient pool, and the results are far short of what would be needed for the FDA to formally approve the GLP-1 drugs use in alcohol use disorder, it does provide encouragement for companies who are thinking of testing their drugs in the indication in the not-so-distant future
Instead of saying "I think the last dose was okay," you can say "I had mild nausea for two days after each of my last four injections at 7.5mg, but appetite suppression is strong and weight is trending down 1.2 pounds per week." That level of detail leads to better clinical decisions
And while some companies, such as Lilly, are testing their analogs as stand-alone therapies, others, including Novo Nordisk, are combining them with GLP-1s
I would hypothesize that weight will be maintained lower than when you started, but whether it'll be maintained, the exact weight you achieved after one or two years, I don't know